AEGiS-WSJ: Health: Bayer to Pay $265 Million In U.S. AIDS Settlement Wall Street JournalImportant note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Click here to return to Wall Street Journal main menu




DonateNow



Health: Bayer to Pay $265 Million In U.S. AIDS Settlement

The Wall Street Journal - Wednesday, 7 May 1997.


LEVERKUSEN, Germany (AP) -- Bayer AG said it expects to pay some 460 million marks ($265 million) to the survivors of more than 6,000 AIDS victims in the U.S. infected by tainted blood products between 1978 and 1985.

Bayer spokeswoman Christina Sehnert confirmed Bayer was close to agreement on the AIDS cases, in which three other companies also are involved.

Bayer, Baxter International Inc., Rhone-Poulenc Rorer Inc. and Alpha Terapeutics Inc. already had reached agreement in April 1996 to settle with some 6,200 U.S. AIDS victims or their survivors for $100,000 each. But the settlements were held up as the U.S. government and several states, including New Jersey, sought reimbursement for medical bills incurred treating hemophiliacs with AIDS.

Ms. Sehnert said that agreements were near on legal costs as well as with the states and federal government on medical costs.

Last year's agreement alone will cost the four companies some $600 million, with Bayer's share close to $270 million. The companies also offered $12 million for medical care of the patients.


Keywords: AIDS VICTIMS; AIDS CASESKWDaidsvictims;aidscases
970507
WJ970504

Copyright © 1997 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .